Miller Anestesia

306. Rudick RA, Cohen JA, Weinstock-Guttman B, et al:

Management of multiple sclerosis. N Engl J Med

337:1604, 1997.

307. Kocabas S,Karaman S,Firat V,Bademkiran E:Anes-

thetic management of Guillain-Barré syndrome in

pregnancy. J Clin Anesth 19:299–302, 2007.

308. McKhann GM, Griffin JW, Cornblath DR, et al:

Plasmapheresis and Guillain-Barré syndrome:

Analysis of prognostic factors and the effect of

plasmapheresis. Ann Neurol 23:347, 1988.

309. Toh B-H, van Driel IR, Gleeson PA: Pernicious

anemia. N Engl J Med 337:1441, 1997.

310. Jensen NF, Fiddler DS, Striepe V: Anesthetic consi-

derations in porphyrias. Anesth Analg 80:591,

1995.

311. Kantor G, Rolbin SH: Acute intermittent porphyria

and caesarean delivery. Can J Anaesth 39:282,

1992.

312. Meissner PN, Harrison GG, Hift RJ: Propofol as an

I.V.anaesthetic induction agent in variegate porphy-

ria. Br J Anaesth 66:60, 1991.

313. McNeill MJ, Bennet A: Use of regional anaesthesia

in a patient with acute porphyria. Br J Anaesth

64:371, 1990.

314. Massey JM: Treatment of acquired myasthenia

gravis. Neurology 48:S46–S51, 1997.

315. d’Empaire G, Hoaglin DC, Perlo VP, et al: Effect of

prethymectomy plasma exchange on postoperative

respiratory function in myasthenia gravis. J Thorac

Cardiovasc Surg 89:592, 1985.

316. Eisenkraft JB, Book WJ, Mann SM, et al: Resistance

to succinylcholine in myasthenia gravis: A dose

response study. Anesthesiology 69:760, 1988.

317. Eisenkraft JB, Papatestas AE, Kahn CH, et al: Pre-

dicting the need for postoperative mechanical

ventilation in myasthenia gravis. Anesthesiology

65:79, 1986.

318. Small S, Ali HH, Lennon VA, et al: Anesthesia for

unsuspected Lambert-Eaton myasthenic syndrome

with autoantibodies and occult small cell lung car-

cinoma. Anesthesiology 76:142, 1992.

319. Lema G, Urzua J, Moran S, Canessa R: Successful

anesthetic management of a patient with hypokale-

mic familial periodic paralysis undergoing cardiac

surgery. Anesthesiology 74:373, 1991.

320. Ashwood EM, Russell WJ, Burrow DD: Hyperkalae-

mic periodic paralysis. Anaesthesia 47:579, 1992.

321. Gutmann DH, Fischbeck KH: Molecular biology of

Duchenne and Becker’s muscular dystrophy: Clini-

cal applications. Ann Neurol 26:189, 1989.

322. Smith CL, Bush GH: Anesthesia and progressive

muscular dystrophy. Br J Anaesth 57:1113, 1985.

323. Schwartz L, Rockoff MA, Koka BV: Masseter spasm

with anesthesia: Incidence and implications. Anes-

thesiology 61:772, 1984.

324. Rosenberg H: Trismus is not trivial [editorial].

Anesthesiology 67:453, 1987.

325. Pueschel SM, Scola FH: Atlantoaxial instability in

individuals with Down syndrome: Epidemiologic,

radiographic, and clinical studies. Pediatrics 80:55,

1987.

326. Morray JP, MacGillivray R, Duker G: Increased

perioperative risk following repair of congenital

heart disease in Down’s syndrome. Anesthesiology

65:221, 1986.

327. Roizen NJ, Patterson D. Down’s syndrome Lancet

361:1281–1289, 2003.

328. Freeman SB, Taft LF, Dopoley KJ, et al: Population-

based study of congenital heart defects in Down

syndrome. Am J Med Genet 80:213–217, 1998.

329. Kobel M, Creighton RE, Steward DJ: Anaesthetic

considerations in Down’s syndrome: Experience

with 100 patients and a review of the literature. Can

J Anaesth 29:593, 1982.

330. Bedford RF, Morris L, Jane JA: Intracranial hyper-

tension during surgery for supratentorial tumor:

Correlation with preoperative computed tomo-

graphy scans. Anesth Analg 61:430, 1982.

331. Ramirez-Lassepas M, Quinones MR: Heparin

therapy for stroke: Hemorrhagic complications and

risk factors for intracerebral hemorrhage. Neuro-

logy 34:114, 1984.

332. Rem JA, Hachinski VC, Boughner DR, Barnett HJ:

Value of cardiac monitoring and echocardiography

in TIA and stroke patients. Stroke 16:950, 1985.

333. Drugs: for psychiatric disorders. Treatment guide-

line. Med Lett Drugs Ther 11:69–76, 2003.

334. Appel GB, Neu HC: The nephrotoxicity of antimi-

crobial agents. N Engl J Med 296: 663, 722,784,

1977.

335. Byrick RJ, Rose DK: Pathophysiology and preven-

tion of acute renal failure: The role of the anaes-

thetist. Can J Anaesth 37:457, 1990.

336. Berns AS: Nephrotoxicity of contrast media. Kidney

Int 36:730, 1989.

337. Myers BD, Moran SM: Hemodynamically mediated

acute renal failure. N Engl J Med 314:97, 1986.

338. Thadhani R, Pascual M, Bonventre JV: Acute renal

failure. N Engl J Med 334:1448, 1996.

339. Aronson S, Thisthelwaite RJ, Walker R, et al: Safety

and feasibility of renal blood flow determination

during surgery with perfusion ultrasonography.

Anesth Analg 80:353, 1995.

340. Hebert PC, Wells G, Blajchman MA, et al: A multi-

center, randomized, controlled clinical trial of

transfusion requirements in critical care. Transfu-

sion Requirements in Critical Care Investigators,

Canadian Critical Care Trials Group. N Engl J Med

340:409–417, 1999.

341. Koch CG, Khandwala F, Li L, et al: Persistant effect

of red cell transfusion on health-related quality of

life after cardiac surgery.AnnThorac Surg 82:13–20,

2006.

342. Rao KV, Anderson RC, O’Brien TJ: Factors contri-

buting for improved graft survival in recipients of

kidney transplants. Kidney Int 24:210, 1983.

343. Coe FL, Parks JH, Asplin JR: The pathogenesis and

treatment of kidney stones. N Engl J Med 327:1141,

1992.

344. Kellen M, Aronson S, Roizen MF, et al: Predictive

and diagnostic tests of renal failure: A review.

Anesth Analg 78:134, 1994.

345. Novis BK, Roizen MF, Aronson S, Thisted RA:

Association of preoperative risk factors with posto-

perative acute renal failure. Anesth Analg 78:143,

1994.

346. Lee TH, Marcantonio ER, Mangione CM, et al:

Derivation and prospective validation of a simple

index for prediction of cardiac risk of major non-

cardiac surgery. Circulation 100:1043–1049,

1999.

347. Mangano CM, Diamondstone LS, Ramsay JG, et al:

Renal dysfunction after myocardial revasculariza-

tion: Risk factors, adverse outcomes, and hospital

resource utilization.The Multicenter Study of Perio-

perative Ischemia Research Group.Ann Intern Med

128:194–203, 1998.

348. Flancbaum L, Choban PS, Dasta JF: Quantitative

effects of low-dose dopamine on urine output in

oliguric surgical intensive care unit patients. Crit

Care Med 22:61, 1994.

349. Paul MD, Mazer CD, Byrick RJ, et al: Influence of

mannitol and dopamine on renal function during

elective infrarenal aortic clamping in man. Am J

Nephrol 6:427, 1986.

350. Crowley K, Clarkson K, Hannon V, et al: Diuretics

after transurethral prostatectomy: A double-blind

controlled trial comparing furosemide and manni-

tol. Br J Anaesth 65:337, 1990.

351. Dorman HR, Sondheimer JH, Cadnapaphornchai

P: Mannitol-induced acute renal failure. Medicine

(Baltimore) 69:153–159, 1990.

352. Kellum JA,Decker J: Use of dopamine in acute renal

failure: A meta-analysis. Crit Care Med 29:1526–

1531, 2001.

353. Alpert RA, Roizen MF, Hamilton WK, et al: Intrao-

perative urinary output does not predict postopera-

tive renal function in patients undergoing

abdominal aortic revascularization. Surgery 95:707,

1984.

354. Halpenny M, Lakshmi S, O’Donnell A, et al: The

effects of fenoldopam on coronary conduit blood

flow after coronary artery bypass graft surgery. J

Cardiothorac Vasc Anesth 15:72–76, 2001.

355. Halpenny M, Rushe C, Breen P, et al: The effects of

fenoldopam on renal function in patients under-

going elective aortic surgery. Eur J Anaesthesiol

19:32–39, 2002.

356. Caimmi PP, Pagani L, Micalizzi E, et al: Fenoldopam

for renal protection in patients undergoing cardio-

pulmonary bypass. J Cardiothorac Vasc Anesth

17:491–494, 2003.

357. Litz RJ, Hubler M, Lorenz W, et al: Renal responses

to desflurane and isoflurane in patients with renal

insufficiency. Anesthesiology 97:1133–1136, 2002.

358. Conzen PF, Kharasch ED, Czerner SF, et al: Low-

flow sevoflurane compared with low-flow isoflurane

anesthesia in patients with stable renal insufficiency.

Anesthesiology 97:578–584, 2002.

359. Petroni KC, Cohen NH: Continuous renal replace-

ment therapy: Anesthetic implications. Anesth

Analg 94:1288–1297, 2002.

360. Renal Data System: USRDS 2001 Annual Data

Report: Atlas of End Stage Renal Disease in the

United States. Bethesda, MD, National Institute of

Diabetes and Digestive and Kidney Diseases,

2001.

361. Myers BD, Sibley R, Newton L, et al: The long-term

course of cyclosporine-associated chronic nephro-

pathy. Kidney Int 33:590, 1988.

362. Bennett WM, Aronoff GR, Morrison G, et al: Drug

prescribing in renal failure: Dosing guidelines for

adults. Am J Kidney Dis 3:155, 1983.

363. Bennett WM, Aronoff GR, Golper TA, et al: Drug

Prescribing in Renal Failure. Dosing Guidelines for

Adults, 2nd ed. Philadelphia, American College of

Physicians, 1991.

364. Goyal P, Puri GD, Pandey CK, Srivastva S: Evalua-

tion of induction doses of propofol: Comparison

between endstage renal disease and normal renal

function patients. Anaesth Intensive Care 30:584–

587, 2002.

365. Platt R, Zaleznik DF, Hopkins CC, et al: Periopera-

tive antibiotic prophylaxis for herniorrhaphy and

breast surgery. N Engl J Med 322:153, 1990.

366. Chestnut DH: Spinal anesthesia in the febrile

patient. Anesthesiology 76:667, 1992.

367. Rackow EC, Astiz ME: Pathophysiology and treat-

ment of septic shock. JAMA 266:548, 1991.

368. Knaus WA, Wagner DP: Multiple systems organ

failure: Epidemiology and prognosis. Crit Care Clin

5:522, 1989.

369. The choice of antibacterial drugs. Med Lett Drugs

Ther 46:13, 2004.

370. Nichol KL, Nordin JD, Nelson DB, et al: Effecti-

veness of influenza vaccine in the community-

dwelling elderly. N Engl J Med 357:1373–1381,

2007.

371. Maki DG, Botticelli JT, Le Roy ML, Thielke TS:

Prospective study of replacing administration sets

for intravenous therapy at 48- vs 72-hour intervals:

72 hours is safe and cost-effective. JAMA 258:1771,

1987.

372. Maki DG, Ringer M: Evaluation of dressing regi-

mens for prevention of infection with peripheral

intravenous catheters: Gauze, a transparent polyu-

rethane dressing, and an iodophor-transparent

dressing. JAMA 258:2396, 1987.

373. Dodd RY: The risk of transfusion-transmitted infec-

tion. N Engl J Med 327:419, 1992.

374. Buergler JM, Kim R, Thisted RA, et al: The risk of

human immunodeficiency virus in surgeons, anes-

thesiologists, and medical students. Anesth Analg

75:118, 1992.

375. Jensen V: The TURP syndrome. Can J Anaesth

38:90, 1991.

376. Ostia JR: The binge-purge syndrome: A common

albeit unappreciated cause of acid-base and fluid

electrolyte disturbances. South Med J 80:58, 1987.

377. Schrier RW:Pathogenesis of sodium and water reten-

tion in high-output and low-output cardiac failure,

nephrotic syndrome, cirrhosis, and pregnancy (Pts 1

and 2). N Engl J Med 319:1065, 1127, 1988.

378. Sterns RH: Severe symptomatic hyponatremia:

Treatment and outcome. Ann Intern Med 107:656,

1987.

912

Control de la anestesia

III